Geode Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29B | Sell |
|
|||||
|
2025
Q1 | $1.56B | Buy |
|
|||||
|
2024
Q4 | $1.73B | Buy |
|
|||||
|
2024
Q3 | $2.38B | Sell |
|
|||||
|
2024
Q2 | $2.53B | Buy |
|
|||||
|
2024
Q1 | $2.28B | Buy |
|
|||||
|
2023
Q4 | $2.06B | Buy |
|
|||||
|
2023
Q3 | $1.91B | Buy |
|
|||||
|
2023
Q2 | $1.64B | Buy |
|
|||||
|
2023
Q1 | $1.82B | Buy |
|
|||||
|
2022
Q4 | $1.59B | Sell |
|
|||||
|
2022
Q3 | $1.54B | Buy |
|
|||||
|
2022
Q2 | $1.31B | Buy |
|
|||||
|
2022
Q1 | $1.46B | Buy |
|
|||||
|
2021
Q4 | $1.25B | Buy |
|
|||||
|
2021
Q3 | $1.05B | Buy |
|
|||||
|
2021
Q2 | $951M | Buy |
|
|||||
|
2021
Q1 | $760M | Buy |
|
|||||
|
2020
Q4 | $765M | Sell |
|
|||||
|
2020
Q3 | $982M | Buy |
|
|||||
|
2020
Q2 | $947M | Buy |
|
|||||
|
2020
Q1 | $649M | Buy |
|
|||||
|
2019
Q4 | $475M | Buy |
|
|||||
|
2019
Q3 | $344M | Buy |
|
|||||
|
2019
Q2 | $363M | Buy |
|
|||||
|
2019
Q1 | $450M | Buy |
|
|||||
|
2018
Q4 | $402M | Buy |
|
|||||
|
2018
Q3 | $403M | Buy |
|
|||||
|
2018
Q2 | $334M | Buy |
|
|||||
|
2018
Q1 | $322M | Buy |
|
|||||
|
2017
Q4 | $330M | Buy |
|
|||||
|
2017
Q3 | $379M | Buy |
|
|||||
|
2017
Q2 | $407M | Buy |
|
|||||
|
2017
Q1 | $283M | Buy |
|
|||||
|
2016
Q4 | $246M | Buy |
|
|||||
|
2016
Q3 | $256M | Buy |
|
|||||
|
2016
Q2 | $222M | Sell |
|
|||||
|
2016
Q1 | $231K | Buy |
|
|||||
|
2015
Q4 | $339M | Buy |
|
|||||
|
2015
Q3 | $288M | Buy |
|
|||||
|
2015
Q2 | $306M | Buy |
|
|||||
|
2015
Q1 | $262M | Buy |
|
|||||
|
2014
Q4 | $231M | Buy |
|
|||||
|
2014
Q3 | $194M | Sell |
|
|||||
|
2014
Q2 | $164M | Buy |
|
|||||
|
2014
Q1 | $173M | Buy |
|
|||||
|
2013
Q4 | $157M | Buy |
|
|||||
|
2013
Q3 | $172M | Buy |
|
|||||
|
2013
Q2 | $117M | Buy |
|